Literature DB >> 1688471

The dominant W42 spotting phenotype results from a missense mutation in the c-kit receptor kinase.

J C Tan1, K Nocka, P Ray, P Traktman, P Besmer.   

Abstract

The murine white spotting locus (W) is allelic with the proto-oncogene c-kit, which encodes a transmembrane tyrosine protein kinase receptor for an unknown ligand. Mutations at the W locus affect various aspects of hematopoiesis and the proliferation and migration of primordial germ cells and melanoblasts during development to varying degrees of severity. The W42 mutation has a particularly severe effect in both the homozygous and the heterozygous states. The molecular basis of the W42 mutation was determined. The c-kit protein products in homozygous mutant mast cells were expressed normally but displayed a defective tyrosine kinase activity in vitro. Nucleotide sequence analysis of mutant complementary DNAs revealed a missense mutation that replaces aspartic acid with asparagine at position 790 in the c-kit protein product. Aspartic acid-790 is a conserved residue in all protein kinases. These results provide an explanation for the dominant nature of the W42 mutation and provide insight into the mechanism of c-kit-mediated signal transduction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1688471     DOI: 10.1126/science.1688471

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  78 in total

1.  Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2.

Authors:  E J Huang; K H Nocka; J Buck; P Besmer
Journal:  Mol Biol Cell       Date:  1992-03       Impact factor: 4.138

2.  Interkinase domain of kit contains the binding site for phosphatidylinositol 3' kinase.

Authors:  S Lev; D Givol; Y Yarden
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

Review 3.  Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression.

Authors:  Karl Staser; Feng-Chun Yang; D Wade Clapp
Journal:  Annu Rev Pathol       Date:  2011-11-07       Impact factor: 23.472

4.  Genetic evidence for critical roles of P38α protein in regulating mast cell differentiation and chemotaxis through distinct mechanisms.

Authors:  Ping Hu; Nadia Carlesso; Mingjiang Xu; Yan Liu; Angel R Nebreda; Clifford Takemoto; Reuben Kapur
Journal:  J Biol Chem       Date:  2012-04-19       Impact factor: 5.157

5.  Effect of alleles Wv and Wy of the dominant white spotting mutation on the preimplantation development of mice.

Authors:  N Yu Sakharova; A M Malashenko; E F Vikhlyantseva; Yu A Kovalitskaya; L M Chailakhyan
Journal:  Dokl Biol Sci       Date:  2004 Sep-Oct

6.  Heterozygous kit mutants with little or no apparent anemia exhibit large defects in overall hematopoietic stem cell function.

Authors:  Yashoda Sharma; Clinton M Astle; David E Harrison
Journal:  Exp Hematol       Date:  2007-02       Impact factor: 3.084

7.  Characterization of a member of the immunoglobulin gene superfamily that possibly represents an additional class of growth factor receptor.

Authors:  Y H Chou; M J Hayman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

8.  Mouse platelet-derived growth factor receptor alpha gene is deleted in W19H and patch mutations on chromosome 5.

Authors:  E A Smith; M F Seldin; L Martinez; M L Watson; G G Choudhury; P A Lalley; J Pierce; S Aaronson; J Barker; S L Naylor
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

9.  Platelet-derived growth factor receptor alpha-subunit gene (Pdgfra) is deleted in the mouse patch (Ph) mutation.

Authors:  D A Stephenson; M Mercola; E Anderson; C Y Wang; C D Stiles; D F Bowen-Pope; V M Chapman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

10.  Activation and inhibition of erythropoietin receptor function: role of receptor dimerization.

Authors:  S S Watowich; D J Hilton; H F Lodish
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.